Table 2 Renal factors of six-week mortality in patients with AKI (n = 153)
From: Impact of acute kidney injury on mortality in patients with acute variceal bleeding
All patients (n = 153) | No Death (n = 110) | Death (n = 43) | P | |
|---|---|---|---|---|
Baseline sCr, mg/dL | 0.75 (0.62–0.93) | 0.71 (0.59–0.83) | 0.91 (0.72–1.19) | < 0.001 |
sCr at admission, mg/dL | 1.12 (0.84–1.58) | 1.13 (0.83–1.55) | 1.05 (0.87–1.65) | 0.761 |
sCr at initial AKI | 1.46 (1.18–2.03) | 1.32 (1.13–1.74) | 2.05 (1.50–2.80) | < 0.001 |
Peak sCr, mg/dL | 1.58 (1.20–2.32) | 1.36 (1.14–1.77) | 2.67 (1.91–3.76) | < 0.001 |
Initial AKI stage | < 0.001 | |||
Stage 1a | 64 (41.8%) | 58 (52.7%) | 6 (14.0%) | |
Stage 1b | 30 (19.6%) | 16 (14.5%) | 14 (32.6%) | |
Stage 2 | 39 (25.5%) | 29 (26.4%) | 10 (23.3%) | |
Stage 3 | 20 (13.1%) | 7 (6.4%) | 13 (30.2%) | |
Progression of AKI | 30 (19.6%) | 7 (6.4%) | 23 (53.5%) | < 0.001 |
Need for RRT | 19 (12.4%) | 1 (0.9%) | 18 (41.9%) | < 0.001 |
Peak AKI stage | < 0.001 | |||
Stage 1a | 56 (36.6%) | 53 (48.2%) | 3 (7.0%) | |
Stage 1b | 27 (17.6%) | 19 (17.3%) | 8 (18.6%) | |
Stage 2 | 37 (24.2%) | 30 (27.3%) | 7 (16.3%) | |
Stage 3 | 33 (21.6%) | 8 (7.3%) | 25 (58.1%) | |
Cause of AKI | < 0.001 | |||
Prerenal AKI | 131 (85.6%) | 104 (94.5%) | 27 (62.8%) | |
HRS | 18 (11.8%) | 3 (2.7%) | 15 (34.9%) | |
Intrinsic | 4 (2.6%) | 3 (2.7%) | 1 (2.3%) |